大韓民国でのアルツハイマー病治療に最適なクリニックと費用をご発見ください2026

The latest Alzheimer drug available in South Korea is Leqembi (lecanemab). The Ministry of Food and Drug Safety (MFDS) approved it in May 2024. It launched for clinical use in November 2024. This monoclonal antibody targets amyloid-beta plaques to slow cognitive decline.

• Approval status: MFDS authorized the drug for mild dementia and cognitive impairment.
• Administration method: Patients receive the treatment through intravenous infusions every two weeks.
• Eligibility criteria: Confirmation of amyloid plaques via PET scan or CSF analysis is required.
• Advanced alternatives: Clinics like RE:YOUTH also offer arterial stem cell therapy for dementia.

Bookimed Expert Insight: While major centers like Asan Medical Center and Severance Hospital offer standard drug therapies, specialty clinics are emerging with localized delivery methods. RE:YOUTH (YONSEI BH Arterial Stemcell Clinic) utilizes a unique arterial delivery technology. This targets the brain directly through the blood-brain barrier. Data shows these specialized centers often provide faster access to innovative approaches than the high-volume public hospitals.

Patient Consensus: Patients note that getting biomarker testing early is essential because PET scan schedules fill up quickly in Seoul. Many recommend checking eligibility for clinical trials at university hospitals to access newer medications before they receive full insurance coverage.

Eligible patients must have mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Success requires early-stage diagnosis confirmed by elevated amyloid plaques via PET scans or lumbar punctures. Candidates must maintain specific cognitive scores and have no severe vascular brain disease or anticoagulation needs.

• Cognitive scores: Most protocols require Mini-Mental State Examination (MMSE) scores between 22 and 30.
• Biomarker verification: Physicians must confirm amyloid plaque presence through PET scans or cerebrospinal fluid analysis.
• Safety screen: Patients with over four microhemorrhages on MRI are disqualified due to swelling risks.
• Drug restrictions: Individuals taking full-strength blood thinners are ineligible to prevent serious brain bleeding.

Bookimed Expert Insight: While major centers like Severance Hospital serve over 1.6 million outpatients, early intervention is vital because these drugs slow rather than reverse progression. Our data shows that top Korean clinics often prioritize patients under 65 for specialized research arms. Confirming amyloid status via PET scans at high-volume facilities like Asan Medical Center before symptoms worsen improves inclusion odds.

Patient Consensus: Patients note that testing APOE4 status privately helps avoid eligibility surprises later. Many emphasize that rural residents must travel to Seoul, as primary access to these infusions and specialized MRI monitoring remains concentrated in major capital hospitals.

Wait times for dementia specialists in Korea typically range from 24 to 62 days at major national university hospitals. While local clinics often provide same-week appointments, top-tier centers like Seoul National University Hospital (SNUH) currently report average waits of 57 to 62 days. Patients find faster access in Seoul than rural areas.

• University hospital waits: Average outpatient delays span 35 to 62 days.
• Local clinic access: Non-emergency appointments usually take a few days.
• Specialist clinic speed: Private neurology slots often book within two weeks.
• Seoul vs regional: Rural areas may have delays reaching up to 2 months.

Bookimed Expert Insight: While major centers like Asan Medical Center serve over 11,000 outpatients daily, wait times for neurology stay manageable through digital systems. Choosing a clinic with Newsweek-ranked digital infrastructure, such as the BESTcare system at Seoul National University Bundang Hospital, often correlates with more efficient patient flow and scheduling.

Patient Consensus: Patients note that using hospital mobile apps or getting a local referral significantly speeds up the booking process in Seoul. Most report that initial specialist visits usually happen within 10 days despite the heavy volume at major hospitals.

Experimental treatments like arterial stem cell therapy and mesenchymal stem cell research are available in South Korea. Specialized centers use advanced delivery methods to target brain tissue directly. These therapies remain in clinical stages. Patients must verify current trial status through official medical channels.

• Arterial delivery: RE:YOUTH clinic uses interventional radiology to deliver cells directly to target organs.
• Neurological expertise: Dr. Byung-hee Lee is a founding member of the Korean Stroke Society.
• Advanced diagnostics: Top-tier centers like Severance Hospital use JCI-accredited protocols for neurological screening.
• Research volume: Leading academic institutions like SNUBH manage over 1.5 million patient visits annually.

Bookimed Expert Insight: While many facilities offer standard intravenous injections, the RE:YOUTH clinic in Cheonan differentiates itself by using an arterial delivery method. This technique aims to bypass the lungs and deliver concentrated stem cells directly to the brain via the carotid artery. This specialized approach is rare even in major medical hubs like Seoul.

Patient Consensus: Patients note it is vital to distinguish between commercial clinics and official clinical trials. Many suggest consulting neurologists at large university hospitals to find legitimate research opportunities rather than paying for unproven private treatments.

Government support for dementia includes diagnostic coverage through Medicare Part B and long-term care via Medicaid. Specialized programs provide care navigation, home modifications, and expedited disability benefits. Local agencies offer managed resources like meal delivery and respite grants to support caregivers and patients.

• Medicare coverage: Includes cognitive assessments during annual visits and necessary laboratory diagnostic testing.
• Medicaid assistance: Serves as the primary payer for long-term custodial nursing home care.
• Veteran benefits: Providers offer increased pensions and grants for home safety modifications.
• Expedited claims: Social Security fast-tracks benefits for patients with early-onset dementia types.
• Caregiver grants: Federal programs fund respite care to give family members necessary breaks.

Bookimed Expert Insight: While government programs provide basic care, South Korean centers like Asan Medical Center and Severance Hospital offer advanced digital monitoring. Asan Medical Center manages over 10,000 outpatients daily, indicating a high-volume system that integrates government-supported standards with advanced AI diagnostics. This scale allows for more precise staging than smaller regional clinics.

Patient Consensus: Patients note that navigating federal programs is easier with a dedicated care coordinator. Many emphasize that securing home modification grants early significantly improves daily safety and comfort.

International patients find English support through dedicated international centers at JCI-accredited facilities like Severance Hospital and Asan Medical Center. These centers provide bilingual coordinators and medical interpreters. Coordination teams manage clinical appointments, travel logistics, and visa processing to ensure seamless communication for neurology patients.

• International patient centers: Specialized hospital departments manage translation, scheduling, and logistics.
• Bilingual medical staff: Large institutions like SNUBH employ board-certified specialists with international training.
• Translation technologies: Digital systems like BESTcare help doctors share medical records in English.
• Professional coordination: Dedicated clinics like RE:YOUTH provide expert medical coordination for international arrivals.

Bookimed Expert Insight: While major Seoul hospitals handle over 1,000,000 patients annually, choose centers with specific international accreditations like GHA. These facilities often have more robust English-speaking infrastructure for complex neurological cases. Smaller clinics like RE:YOUTH specialize in niche therapies and provide more personalized English coordination than general hospitals.

Patient Consensus: Patients note that while major Seoul hospitals have English signage, a bilingual companion is often essential for detailed Alzheimer's consultations. Use translation apps like Papago or Google Translate to bridge communication gaps during diagnostic evaluations and daily travel.

Alzheimer's antibody treatments in South Korea, such as lecanemab, carry risks of Amyloid-Related Imaging Abnormalities (ARIA). These involve brain swelling or micro-haemorrhages. Most cases show no symptoms, but some cause headaches or confusion. Specialist clinics like Severance Hospital use MRI monitoring to manage these risks safely.

• Brain swelling: ARIA-E represents fluid build-up in the brain tissue.
• Micro-haemorrhages: ARIA-H involves small spots of bleeding on the brain surface.
• Genetic risk: Global trials show APOE4 gene carriers face up to 33% higher risk.
• Infusion reactions: Patients may experience fever, chills, or blood pressure changes during treatment.

Bookimed Expert Insight: South Korea's digital healthcare infrastructure offers a safety advantage for managing antibody side effects. Hospitals like Seoul National University Bundang Hospital use the BESTcare digital system to track patient data. This helps neurologists monitor MRI schedules and infusion reactions with fewer medical errors. For complex cases, choosing a JCI-accredited centre like Severance Hospital ensures international safety standards during the first 6 months.

Patient Consensus: Families in the Republic of Korea often worry about distinguishing treatment-related confusion from dementia progression. They recommend choosing a centre with clear protocols for MRI frequency. They also suggest checking if the team has experience managing ARIA-related symptoms like dizziness or visual changes.

South Korea employs a structured, government-backed approach to Alzheimer's diagnosis. It uses the culturally tailored Cognitive Impairment Screening Test (CIST) instead of Western standards. High-density Amyloid PET imaging starts earlier in the diagnostic pathway than in many Western protocols. This allows for precise, early identification of amyloid-beta proteins.

• Screening tools: The CIST replaces text-based MMSE with picture-based items for better accuracy.
• Early detection: Formal recognition of subjective cognitive decline results in regular 1–2 year follow-ups.
• Monitoring: The national JOY-ALZ registry tracks real-world data and therapy outcomes.
• Imaging priority: Specialised guidelines require frequent MRI and PET monitoring for therapy-related imaging abnormalities.

Bookimed Expert Insight: South Korean clinics demonstrate a significant focus on neurology. Five of the country's top hospitals appear on Newsweek's Best Hospitals list. Specialists like Dr Yeon Jung Kim at Asan Medical Center use family-inclusive consultations with high-volume research. This expertise, combined with arterial stem cell infusion at clinics like RE:YOUTH, offers unique diagnostic intersections. These are rarely seen in Western primary care.

Patient Consensus: Patients find that Korean clinics often coordinate multidisciplinary assessments during a single visit. These assessments involve neurologists and imaging specialists. They note that the process is heavily imaging-based. PET scans and biomarker testing are discussed much earlier than in Australia.

South Korea offers amyloid-targeting monoclonal antibodies like Lecanemab and regenerative therapies. These disease-modifying treatments slow cognitive decline in early-stage Alzheimer's. Leading JCI-accredited centres in Seoul integrate these with PET imaging for precise amyloid plaque staging.

• Regenerative medicine: RE:YOUTH clinic specialises in arterial stem cell therapy for dementia.
• Drug therapies: Lecanemab (Leqembi) targets amyloid-β protofibrils to slow disease progression.
• Precision diagnostics: Centres use PET imaging like florbetaben to identify eligible patients.
• Specialist expertise: Dr Byung-hee Lee is a founding member for interventional neurology.

Bookimed Expert Insight: South Korea combines traditional academic neurology with specialised regenerative clinics. Major hospitals like Severance Hospital handle 1.6 million outpatients with standard care. In contrast, smaller centres like RE:YOUTH limit intake to 2 patients daily. This focus allows for personalised attention during complex arterial stem cell infusions.

Doctors in South Korea administer donanemab via intravenous infusion every 4 weeks. Treatment takes place in JCI-accredited hospitals or specialised neurology centres. Patients receive the 30-minute infusion under medical supervision. This allows monitoring for amyloid-related imaging abnormalities.

• Infusion method: Medication enters the bloodstream directly through a 30-minute intravenous drip.
• Clinical setting: Dedicated infusion centres at major hospitals manage the process.
• Safety monitoring: Specialists use MRI scans to check for brain swelling or bleeding.
• Patient selection: Neurologists confirm Alzheimer's pathology and APOE4 gene status before starting.
• Treatment frequency: Standard protocols require one hospital visit every 4 weeks for infusions.

Bookimed Expert Insight: South Korea is a global neurology hub with 76 clinics served. Leading facilities like Asan Medical Center integrate dementia care with researchers from the Korean Dementia Association. Patients benefit from specialists like Dr Yeon Jung Kim, who trained at New York-Presbyterian Hospital. This global training helps ensure Australian patients receive treatment following protocols used in the USA.

Patient Consensus: Patients note that treatment in South Korea requires careful logistics for regular hospital visits. They emphasise planning for recovery time and repeated MRI scans after each infusion session.

South Korea provides structured medical and social support for Alzheimer's patients through the National Dementia Plan. Major centres such as Severance Hospital and Asan Medical Center offer specialised neurology care. Support includes diagnostic screenings, dedicated dementia care specialists, and long-term care insurance subsidies for eligible residents.

• Specialised neurology units: JCI-accredited facilities like Gangnam Severance Hospital provide expert neurological and neurosurgical care.
• Clinical diagnostics: Clinics use high-resolution CT and ECG to monitor cognitive and physical health.
• Integrated safety systems: SNUBH uses the BESTcare digital system to reduce medical errors during treatment.
• Expert physician involvement: Specialists such as Dr Yeon Jung Kim include families in treatment discussions.

Bookimed Expert Insight: South Korea's national support network is extensive. However, many community-based subsidies apply only to residents. International patients should prioritise hospitals with Global Healthcare Accreditation (GHA). Seoul National University Bundang Hospital is one such hospital. These institutions are vetted for how they handle the needs of patients travelling from abroad.

Patient Consensus: International families should not expect automatic access to local community programs. Patients note it is essential to arrange personal caregiver support. It is also important to confirm English-speaking staff availability in Korea before arrival.